We are live on
!
Find out more
SC
Samlyn Capital Portfolio holdings
AUM
$6.14B
1-Year Est. Return
42.05%
This Fund
S&P 500
This Quarter
Est. Return
+11.19%
1 Year Est. Return
+42.05%
3 Year Est. Return
+148.08%
5 Year Est. Return
+210.34%
10 Year Est. Return
+1,110.53%
AUM
$6.82B
AUM Growth
-$426M
(-5.9%)
Cap. Flow
-$803M
Cap. Flow
% of AUM
-11.77%
Top 10 Holdings %
Top 10 Hldgs %
37.78%
Holding
211
New
63
Increased
45
Reduced
53
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$114M |
| 2 |
KKR & Co
KKR
|
+$113M |
| 3 |
Walt Disney
DIS
|
+$93.6M |
| 4 |
MetLife
MET
|
+$83.2M |
| 5 |
GFL Environmental
GFL
|
+$57.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$236M |
| 2 |
Target
TGT
|
+$191M |
| 3 |
Morgan Stanley
MS
|
+$174M |
| 4 |
Interactive Brokers
IBKR
|
+$111M |
| 5 |
Uber
UBER
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.62% |
| 2 | Consumer Discretionary | 20.17% |
| 3 | Healthcare | 13.24% |
| 4 | Communication Services | 12.31% |
| 5 | Miscellaneous | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATH
26
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $96.5M | 1.41% |
1,429,090
-3,925,042
| -73% | -$236M |
|
27
PureCycle Technologies
PCT
$1.28B
| $82.2M | 1.21% |
3,476,008
+189,575
| +6% | +$4.08M |
|
|
28
MetLife
MET
$62B
| $78.6M | 1.15% |
+1,313,039
| New | +$83.2M |
|
29
W.R. Berkley
WRB
$25.7B
| $73.2M | 1.07% |
2,212,058
-1,000,760
| -31% | -$34.6M |
|
30
T-Mobile US
TMUS
$195B
| $72M | 1.06% |
496,848
-281,071
| -36% | -$38.8M |
|
31
Merck
MRK
$371B
| $68.7M | 1.01% |
882,763
-749,657
| -46% | -$55.8M |
|
32
Wayfair
W
$13.6B
| $67.7M | 0.99% |
214,315
-137,950
| -39% | -$43.2M |
|
33
Jazz Pharmaceuticals
JAZZ
$16B
| $59M | 0.87% |
332,033
+131,614
| +66% | +$22.8M |
|
|
SBNY
34
DELISTED
Signature Bank
SBNY
| $58.5M | 0.86% |
238,018
-129,323
| -35% | -$31.4M |
|
|
35
GFL Environmental
GFL
$19.1B
| $56.4M | 0.83% |
+1,766,654
| New | +$57.8M |
|
|
TWTR
36
DELISTED
Twitter, Inc.
TWTR
| $55.9M | 0.82% |
812,289
+252,219
| +45% | +$15.5M |
|
37
Signet Jewelers
SIG
$3.31B
| $50.1M | 0.73% |
619,627
-172,535
| -22% | -$11.2M |
|
38
Hillman Solutions
HLMN
$1.49B
| $49.6M | 0.73% |
4,001,155
-491,423
| -11% | -$5.48M |
|
39
Capri Holdings
CPRI
$1.54B
| $49.3M | 0.72% |
861,263
-365,265
| -30% | -$19.9M |
|
40
Arthur J. Gallagher & Co
AJG
$67.3B
| $48.6M | 0.71% |
+347,203
| New | +$49.1M |
|
41
Under Armour
UAA
$2.26B
| $46.7M | 0.68% |
2,208,143
+832,880
| +61% | +$18.6M |
|
42
Perella Weinberg Partners
PWP
$1.3B
| $46.4M | 0.68% |
3,607,389
+690,875
| +24% | +$8.15M |
|
43
International Flavors & Fragrances
IFF
$22B
| $46.3M | 0.68% |
310,110
-51,750
| -14% | -$7.43M |
|
|
ITCI
44
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $46M | 0.68% |
1,127,615
-241,991
| -18% | -$8.94M |
|
45
LyondellBasell Industries
LYB
$20.5B
| $44.5M | 0.65% |
432,678
-97,560
| -18% | -$10.6M |
|
46
Avantor
AVTR
$10.1B
| $43.1M | 0.63% |
+1,212,457
| New | +$39.2M |
|
47
Envista
NVST
$4.38B
| $43M | 0.63% |
+995,527
| New | +$43.2M |
|
|
SIX
48
DELISTED
Six Flags Entertainment Corp.
SIX
| $41M | 0.6% |
947,406
-234,188
| -20% | -$10.6M |
|
|
SGEN
49
DELISTED
Seagen Inc. Common Stock
SGEN
| $40.8M | 0.6% |
+258,583
| New | +$38.4M |
|
50
Ashland
ASH
$3.34B
| $40.1M | 0.59% |
458,280
-214,981
| -32% | -$19.4M |
|
Similar funds
MF
LP
SLI
MSU
EQF
PAMP
WCM
MOS
Samlyn Capital's Q2 2021 Portfolio in Review
As of Q2 2021, Samlyn Capital held 211 positions worth $6.82B, down 5.9% from $7.25B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Samlyn Capital withdrew a net $803M in Q2 2021, closing 48 positions and reducing 53 holdings. Its most notable exit was Morgan Stanley, an estimated $174M position sold in full.
By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Samlyn Capital opened a new position in Biogen worth $130M.
- Samlyn Capital's largest Q2 2021 buy was Biogen: 376,231 shares worth $130M.
- Samlyn Capital added most to Walt Disney in Q2 2021, an estimated $93.6M increase.
- Samlyn Capital's biggest Q2 2021 reduction was Athene Holding Ltd. Class A Common Shares, cutting an estimated $236M.
- Samlyn Capital fully exited Morgan Stanley in Q2 2021, selling an estimated $174M.
- Samlyn Capital's ten largest holdings make up 38% of its $6.82B portfolio in Q2 2021.
- Samlyn Capital opened 63 new positions and closed 48 in Q2 2021.
- Samlyn Capital's portfolio value fell 5.9% quarter-over-quarter to $6.82B.
Based on Samlyn Capital's 13F filing for Q2 2021, filed 16 Aug 2021.